We investigated four probands, and the kindred of three, with familial dysalbumiriemic hyperthyroxinemia, using the oneand two-steptestsforfree thyroxinand otherthyroid-function tests. The resultsindicatethat this is an autosomaldominant trait. The discoveryof eight cases in our patient population, which represents about 4% of our hyperthyroxinemic patients (8/320), duringeight monthsindicatesthat this aberrationis more common than suspected. 
euthyroid patients have above-normal values for TF4 in serum, FF41 , and FF4 by a single-stepradioimmunoassay (RIA).3 These findings are caused by preferential binding of T4 to an abnormal albumin rather than to the hormonalbinding sites on thyroxin-binding globulin (1). The FT value is normal in thesepatientswhen measured by a twostep RIA kit method or the more cumbersome equilibrium dialysis method.
We have studied four such patients and the kindred of three-the fourth refusing any further investigation-and have verified these findings.
The importance of FDH lies in the fact that these abovenormal laboratory test results have been interpreted as indicating thyrotoxicosisand, consequently,patients have been erroneously treated.To date, only about 58 patients have been reported (2-7), but we believe the syndrometo be more prevalent than the literature suggests.
Materials and Methods
The subjects were among those patients referred to the clinical laboratory by their physicians for routine assessment of their thyrometabolic status. In our laboratory, the initial thyroid-evaluation study is the one-step determina- 
Results
One of us (A.G.S.) examined the medical records of each patient.
The test results were discussed with the attending physicians.To their knowledge, none of the patients had any evidenceof thyroid disease,and nonewas receiving any medication.
Results of thyroid-function tests are tabulated in Table 1 . The normal reference intervals were derived from values for healthy men and women attending our multiphasic screeningprogram.
We attempted to study the kindred of all four subjectsbut were unsuccessful in getting data from one patient (G.M.), whose immediate family was not available. Results of thyroid-functiontestsfor the kindred of the remaining three patients are also presented in Table 1 with corresponding pedigrees in Figure 1 . We find that at least one memberof a previousor subsequentgeneration has Ff11. In the caseof J.R., both situationspertain-that is, her father and daughter are affected-confirming the impressionthat the modeof transmission is by an autosomaldominant gene.As with the propositi, the affected members have normal results for corroboratory thyroid-function tests, viz., serum Fr4 (twostepmethod), RT3U, and thyroxin-binding globulin.
Discussion
FDH, a recently discoveredsyndrome, is relatively unknown to many clinicians. We believe it to be more common than previously suspected. Its importance is that these patients are mistakenly thought to be thyrotoxic by their physicianswhen in fact they are euthyroid. Somehave even been treated (8) .
The features and pathophysiology have been described
The increase in 'VF4 is due to the presence of an abnormal albumin in the serum of the Reference to the section on Materials and Methods will answer that question. In the one-step FF4 method, all ingredients-i.e., the test serum and (1ItT4 analog-are addedconcurrently into a single antibody-coated test tube.
The labeledanalog,which doesnot bind to normal albumin, is avidly bound by the abnormal albumin; hence, less is boundto the antibody-coated tube and lessradioactivity is measured when the contents are decanted and the tube's radioactivity is counted. Becausethe serum T4 concentration and radioactivity are inversely related, the serum VP4 concentrationis read as being correctly but artifactually abovenormal. In the two-stepmethod,the test serum is first introduced into the antibody-coatedtube; after a suitable period of incubation the serum is discarded, the coating of the tube washed,and the radiolabeled material introduced.
Again, after a designated incubation interval, the contents are decanted, the tube coating is washed, and the amount of residual radioactivity is determined.
In brief: the two-step method does not permit contact between the labeled T4 and the abnormal albumin in the patient's serum. However, one must remember that the latter would be increased in the presence of increased thyroxin-binding globulin, in which case an assay for free triiodothyrornne would also be indicated. Currently in our laboratory, the basic screening test for thyrometabolic status is the one-step FF4. If results exceed threefold the upper limit of our normal reference interval, which is 19 ngIL, we then do the two-step test for verification. If the patient is found to be euthyroid, then one must determine to which of the many causes of euthyroid hyperthyroxinemia the case is to be ascribed. Borst et a!.
(11) have thoroughly reviewed thissubject (Table 2 has been modified from their excellent review). Many of these causes are important but uncommon. The most commonly encountered causes are those related to increased thyroid-hormone binding, acquired and inherited.
In conclusion, we emphasize the importance for clinical awareness of this syndrome of FDH, namely, the avoidance of treating these patients with the mistaken diagnosis of thyrotoxicosis.
